1-2 of 2
Enrica Gamba, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PCR-Based Minimal Residual Disease (MRD) Detection Is a Strong Independent Outcome Predictor Also in Rituximab-Intensive Non-ASCT-Based Programs: Results From the ML17638 Multicenter Randomised Phase III Trial for Elderly Follicular Lymphoma (FL) Patients of the Fondazione Italiana Linfomi (FIL)

Marco Ladetto, MD, Chiara Lobetti-Bodoni, MD, Barbara Mantoan, Ph.D, Andrea Evangelista, Carola Boccomini, MD, Elisa Genuardi, Ph.D, Barbara Botto, Luca Baldini, MD, Giuseppe Rossi, MD, Alessandro Pulsoni, Francesco Di Raimondo, Luigi Rigacci, MD, Antonello Pinto, MD, Mario Petrini, M.D., Ph.D., Stefano Sacchi, Delia Rota-Scalabrini, MD, Luigi Gugliotta, MD, Renato Fanin, MD, Andrea Gallamini, MD, Guido Parvis, MD, Giorgina Specchia, Pellegrino Musto, MD, Barbara Olivero, MD, Enrica Gamba, MD, Giovannino Ciccone, MD, Umberto Vitolo
Journal: Blood
Blood (2012) 120 (21): 787.
https://doi.org/10.1182/blood.V120.21.787.787
Published: 2012
Journal Articles

Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Update of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).

Luca Baldini, MD, Alessandro Pulsoni, MD, Giuseppe Rossi, MD, Umberto Vitolo, Enrica Morra, MD, Barbara Olivero, MD, Elena Cavalieri, MD, Francesco Merli, MD, Luigi Rigacci, Francesco Nobile, MD, Andrea Ferrario, MD, Lorella Orsucci, MD, Maura Brugiatelli, MD, Pellegrino Musto, MD, Giorgio Lambertenghi Deliliers, MD, Enrica Gamba, MD
Journal: Blood
Blood (2009) 114 (22): 2686.
https://doi.org/10.1182/blood.V114.22.2686.2686
Published: 2009